This brand name is authorized in Nigeria.
The drug ASCOCHEW PLUS ZINC contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
PQ6CK8PD0R - ASCORBIC ACID
|
|
Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs. |
|
2
|
UNII
89DS0H96TB - ZINC SULFATE, UNSPECIFIED FORM
|
|
Zinc sulfate is a source of zinc which is an essential trace element and involved in a number of body enzyme systems. Severe deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections and failure to thrive in children. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A11-1021 | Tablet | Ascochew Plus Zinc Tablet TAB 15 mg | Ascochew Plus Zinc Tablet Zinc sulphate Monohydrate 41.2mg ( equv. 15mg elemental zinc); Ascorbic acid 300mg; Starch 129.6mg; Lactose 74. 5mg; HPMC 10mg; SSG 11.3mg; PVPK30 27mg; Methylparaben 2.8mg; Propylparaben 0.4mg; Sunset yellow 1mg; Talc 13.6mg; Magnesium stearate 8.2mg; Aerosil 4.6mg; Microcrystalline cellulose 19.2mg; IPA 22L; Instacoat dark brown 6mg; Drcoat white 11.3mg Tablet Zinc sulphate Monohydrate 41.2mg ( equv. 15mg elemental zinc); Ascorbic acid 300mg; Starch 129.6mg; Lactose 74. 5mg; HPMC 10mg; SSG 11.3mg; PVPK30 27mg; Methylparaben 2.8mg; Propylparaben 0.4mg; Sunset yellow 1mg; Talc 13.6mg; Magnesium stearate 8.2mg; Aerosil 4.6mg; Microcrystalline cellulose 19.2mg; IPA 22L; Instacoat dark brown 6mg; Drcoat white 11.3mg Oral A11-1021 Drugs Over-the-counter (OTC) Diamond Healthcare Limited Neros Pharmaceuticals Ltd NIGERIA 8/26/2021 8/25/2026 Active | 26/08/2021 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A11-1021 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.